|
⚲
|
| GV 2023 GP LLC
✚
|
|
|---|---|
| CIK # | 0001961991, 0001961990 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001961990] | |
| 4 | [0001961990] | |
| D | [0001961990] | |
| 3 | [0001961991] | |
| 4 | [0001961991] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| GV 2017 LP | |
| GV 2019 GP LLC | |
| GV 2019 GP LP | |
| Verve Therapeutics Inc | |
| GV 2019 LP | |
| Alphabet Inc | |
| GV 2023 GP LLC | |
| GV 2023 LP | |
| GV 2017 GP LP | |
| GV 2023 GP LP | |
| GV 2017 GP LLC | |
| Prime Medicine Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Verve Therapeutics Inc VERV
Common Stock
|
2025-07-25 | Tender | 6,108,442 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2025-07-25 | Tender | 4,260,047 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2025-07-25 | Tender | 1,800,000 |